Home LiteratureArticle Details
PMID: 19357177 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

American journal of physiology. Renal physiology ·Vol. 296 ·No. 6 ·2009-06-00 ·Pages F1297-306

Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND

Abstract

A significant reduction of renal mass results in proteinuria, glomerulosclerosis, and tubulointerstitial injury, culminating in end-stage chronic renal failure (CRF). The accumulation of lipids in the kidney can cause renal disease. Uptake of oxidized lipoproteins via scavenger receptors, reabsorption of filtered protein-bound lipids via the megalin-cubilin complex, and increased glucose load per nephron can promote lipid accumulation in glomerular, tubular, and interstitial cells in CRF. Cellular lipid homeostasis is regulated by lipid influx, synthesis, catabolism, and efflux. We examined lipid-regulatory factors in the remnant kidney of rats 11 wk after nephrectomy (CRF) or sham operation. CRF resulted in azotemia, proteinuria, lipid accumulation in the kidney, upregulation of megalin, cubilin, mediators of lipid influx (scavenger receptor class A and lectin-like oxidized receptor-1), lipid efflux (liver X receptor alpha/beta and ATP-binding cassette transporter), and fatty acid biosynthesis (carbohydrate-response element binding protein, fatty acid synthase, and acetyl-CoA carboxylase). However, factors involved in cholesterol biosynthesis (sterol regulatory element binding protein, 3-hydroxy-3-methylglutaryl coenzyme A reductase, SCAP, Insig-1, and Insig-2) and fatty acid oxidation (peroxisome proliferator-activated receptor, acyl-CoA oxidase, and liver-type fatty acid binding protein) were reduced in the remnant kidney. Thus CRF results in heavy lipid accumulation in the remnant kidney, which is mediated by upregulation of pathways involved in tubular reabsorption of filtered protein-bound lipids, influx of oxidized lipoproteins and synthesis of fatty acids, and downregulation of pathways involved in fatty acid catabolism.

MeSH Terms
Animals Carrier Proteins/genetics,metabolism DNA-Binding Proteins/genetics,metabolism Gene Expression Regulation/physiology Kidney/metabolism,pathology Kidney Failure, Chronic/metabolism,pathology Lipid Metabolism/physiology Male Membrane Proteins/genetics,metabolism Rats Rats, Sprague-Dawley
Chemicals
Carrier Proteins DNA-Binding Proteins Membrane Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kim Hyun Ju
Division of Nephrology and Hypertension, University of California, 101 The City Dr., Bldg. 53, Rm. 125, Rt. 81, Orange, CA 92868, USA.
Moradi Hamid
Yuan Jun
Norris Keith
Vaziri Nosratola D
References (60)
60 references, click to expand
  1. Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats.
    Biochim Biophys Acta. 1996 Jun 7;1316(2):132-8 PMID: 8672550
  2. Involvement of glomerular SREBP-1c in diabetic nephropathy.
    Biochem Biophys Res Commun. 2007 Dec 21;364(3):502-8 PMID: 17961514
  3. Scavenger receptors in atherosclerosis: beyond lipid uptake.
    Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1702-11 PMID: 16728653
  4. A simple method for the isolation and purification of total lipides from animal tissues.
    J Biol Chem. 1957 May;226(1):497-509 PMID: 13428781
  5. Atherosclerosis.
    Nature. 2000 Sep 14;407(6801):233-41 PMID: 11001066
  6. The molecular interactions between filtered proteins and proximal tubular cells in proteinuria.
    Nephron Exp Nephrol. 2008;110(2):e67-71 PMID: 18849618
  7. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species.
    J Biol Chem. 2000 Apr 28;275(17):12633-8 PMID: 10777555
  8. Oxidative stress in uremia: nature, mechanisms, and potential consequences.
    Semin Nephrol. 2004 Sep;24(5):469-73 PMID: 15490413
  9. Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure.
    Am J Physiol Renal Physiol. 2004 Jul;287(1):F90-4 PMID: 15010358
  10. The role of the kidney in lipid metabolism.
    Curr Opin Lipidol. 2005 Jun;16(3):301-6 PMID: 15891391
  11. ATP-Binding cassette cholesterol transporters and cardiovascular disease.
    Circ Res. 2006 Nov 10;99(10):1031-43 PMID: 17095732
  12. Cellular lipid metabolism and the role of lipids in progressive renal disease.
    Am J Nephrol. 2004 Jan-Feb;24(1):46-53 PMID: 14707435
  13. Acute tubular injury causes dysregulation of cellular cholesterol transport proteins.
    Am J Pathol. 2003 Jul;163(1):313-20 PMID: 12819036
  14. SREBPs: the crossroads of physiological and pathological lipid homeostasis.
    Trends Endocrinol Metab. 2008 Mar;19(2):65-73 PMID: 18291668
  15. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes.
    Diabetes. 2005 Aug;54(8):2328-35 PMID: 16046298
  16. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions.
    Circulation. 1999 Jun 22;99(24):3110-7 PMID: 10377073
  17. Liver X receptor signaling pathways in cardiovascular disease.
    Mol Endocrinol. 2003 Jun;17(6):985-93 PMID: 12690094
  18. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription.
    Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15597-602 PMID: 15496471
  19. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.
    J Am Soc Nephrol. 2004 Nov;15(11):2801-15 PMID: 15504933
  20. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
    Am J Physiol Renal Physiol. 2004 Nov;287(5):F1038-43 PMID: 15280162
  21. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors.
    Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1116-22 PMID: 10764682
  22. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus.
    J Biol Chem. 2002 May 24;277(21):18919-27 PMID: 11875060
  23. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease.
    Kidney Int. 2005 Dec;68(6):2608-20 PMID: 16316337
  24. Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases.
    Kidney Int. 1993 Apr;43(4):918-27 PMID: 8479130
  25. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.
    Diabetes. 2006 Apr;55(4):885-93 PMID: 16567507
  26. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase.
    Cell Res. 2008 Jun;18(6):609-21 PMID: 18504457
  27. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Diabetes Obes Metab. 2007 May;9(3):369-78 PMID: 17391165
  28. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.
    Cardiovasc Res. 2006 Jan;69(1):36-45 PMID: 16324688
  29. Scavenging new insights into atherogenesis.
    J Clin Invest. 2000 Apr;105(8):1039-41 PMID: 10772646
  30. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway.
    J Biol Chem. 2005 Sep 16;280(37):32317-25 PMID: 16046411
  31. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
    Kidney Int. 2001 Jun;59(6):2192-6 PMID: 11380821
  32. Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease.
    J Am Soc Nephrol. 2005 Aug;16(8):2385-94 PMID: 15944339
  33. Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure.
    Nephrol Dial Transplant. 1999 Jun;14(6):1462-6 PMID: 10383008
  34. [Lipid peroxides in atherosclerotic diseases (author's transl)].
    Nihon Ronen Igakkai Zasshi. 1978 May;15(3):187-91 PMID: 671818
  35. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
    Kidney Int. 2001 Jul;60(1):14-30 PMID: 11422732
  36. Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells.
    Am J Physiol Renal Physiol. 2004 Nov;287(5):F886-95 PMID: 15280160
  37. Atherosclerosis. the road ahead.
    Cell. 2001 Feb 23;104(4):503-16 PMID: 11239408
  38. The fatty acid transport function of fatty acid-binding proteins.
    Biochim Biophys Acta. 2000 Jun 26;1486(1):28-44 PMID: 10856711
  39. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease.
    Lancet. 1982 Dec 11;2(8311):1309-11 PMID: 6128601
  40. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood.
    Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11041-8 PMID: 10500120
  41. Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years.
    Kidney Int. 2001 Jun;59(6):2346-56 PMID: 11380839
  42. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.
    Cell. 1997 May 2;89(3):331-40 PMID: 9150132
  43. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
    J Pharmacol Exp Ther. 2007 Oct;323(1):85-93 PMID: 17636006
  44. CD36: implications in cardiovascular disease.
    Int J Biochem Cell Biol. 2007;39(11):2012-30 PMID: 17466567
  45. SREBP in signal transduction: cholesterol metabolism and beyond.
    Curr Opin Cell Biol. 2007 Apr;19(2):215-22 PMID: 17303406
  46. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.
    Diabetes. 2006 Sep;55(9):2502-9 PMID: 16936198
  47. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits.
    Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):70-9 PMID: 10634802
  48. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
    Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):717-26 PMID: 12006382
  49. Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure.
    Metabolism. 2007 Dec;56(12):1714-8 PMID: 17998026
  50. Lipotoxicity: when tissues overeat.
    Curr Opin Lipidol. 2003 Jun;14(3):281-7 PMID: 12840659
  51. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.
    Kidney Int. 2002 Nov;62(5):1524-38 PMID: 12371953
  52. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
    Transl Res. 2009 Feb;153(2):77-85 PMID: 19138652
  53. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
    Toxicol In Vitro. 2008 Jun;22(4):887-98 PMID: 18299183
  54. Sterol regulatory element-binding proteins, liver X receptor, ABCA1 transporter, CD36, scavenger receptors A1 and B1 in nephrotic kidney.
    Am J Nephrol. 2009;29(6):607-14 PMID: 19147991
  55. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide.
    J Biol Chem. 2001 Apr 27;276(17):13750-5 PMID: 11278710
  56. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
    Pharmacol Ther. 2002 Jul;95(1):89-100 PMID: 12163130
  57. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.
    Cell. 1994 Apr 8;77(1):53-62 PMID: 8156598
  58. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells.
    Circulation. 2000 Jun 27;101(25):2889-95 PMID: 10869259
  59. Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression.
    Am J Pathol. 2003 Jan;162(1):283-91 PMID: 12507911
  60. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER.
    Cell. 2002 Aug 23;110(4):489-500 PMID: 12202038
Article Info
Journal
American journal of physiology. Renal physiology
Abbr.
Am J Physiol Renal Physiol
ISSN
1931-857X
Published
2009-06-00
Epub
2009-00-08
Pages
F1297-306
Language
English
Region
United States
NLM ID
100901990
PMCID
PMC2692452
Subset
IM
Grants
NCRR NIH HHS · 5 U54 RR-0119234 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com